Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.7%

1 terminated/withdrawn out of 27 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
14(58.3%)
N/A
9(37.5%)
Early Phase 1
1(4.2%)
24Total
Phase 1(14)
N/A(9)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT07338058Not ApplicableCompleted

High-Intensity Exercise Snacks for Reducing Mobile Phone Addiction in Adolescents

Role: lead

NCT07341633Not ApplicableActive Not Recruiting

AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

Role: lead

NCT07380750Not ApplicableActive Not Recruiting

Active Families, Healthy Minds: A Family-Centered School Physical Activity Program for Early Adolescents

Role: lead

NCT06966661Not ApplicableCompleted

Peer-Supported E-Health Intervention for College Student Weight Management and Mental Health

Role: lead

NCT07322952Not ApplicableActive Not Recruiting

Gamified Tai Chi Intervention to Improve Executive Function in Children With Autism Spectrum Disorder

Role: lead

NCT06795061Not ApplicableActive Not Recruiting

Fitness Buddy Program to Boost Physical Activity in University Students

Role: lead

NCT06648109Not ApplicableNot Yet Recruiting

Effects of Sleep Body Temperature on Body Composition

Role: lead

NCT06165549Not ApplicableCompleted

Light Therapy for Internet Gaming Disorder

Role: lead

NCT06275061Recruiting

Chinese Obesity and MEtabolic Surgery Database (COMES Database)

Role: lead

NCT06005636Completed

Post-stroke Delirium in Ischemic Stroke Patients

Role: lead

NCT05628545Phase 1Withdrawn

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Role: collaborator

NCT02808416Phase 1Completed

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

Role: collaborator

NCT02709616Phase 1Completed

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Role: collaborator

NCT02808364Phase 1Completed

Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)

Role: collaborator

NCT03506503Not ApplicableCompleted

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Role: lead

NCT03180437Phase 1Completed

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Role: collaborator

NCT03183232Phase 1Completed

Safety and Efficiency of γδ T Cell Against Lung Cancer

Role: collaborator

NCT03183219Phase 1Completed

Safety and Efficiency of γδ T Cell Against Liver Cancer

Role: collaborator

NCT03183206Phase 1Completed

Safety and Efficiency of γδ T Cell Against Breast Cancer

Role: collaborator

NCT03357315Phase 1Completed

Mix Vaccine for Metastatic Sarcoma Patients

Role: collaborator